Notably, higher levels of IL-6 have been associated both with a more intense immune activation during COVID-19 and with autoimmune and chronic inflammatory disease.34–36 However, our study remains hypothesis-generating and further larger studies are needed to confirm these results as well as to clarify whether autoimmune responses may explain these findings in young patients. The gene discussed is IL6; the disease is COVID-19.